OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

D. M. Provencher, C. J. Gallagher, W. R. Parulekar, J. A. Ledermann, D. K. Armstrong, M. Brundage, C. Gourley, I. Romero, A. Gonzalez-Martin, M. Feeney, P. Bessette, M. Hall, J. I. Weberpals, G. Hall, S. K. Lau, P. Gauthier, M. Fung-Kee-Fung, E. A. Eisenhauer, C. Winch, D. TuH. J. Mackay

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)209-210
Number of pages2
JournalObstetrical and Gynecological Survey
Volume73
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Provencher, D. M., Gallagher, C. J., Parulekar, W. R., Ledermann, J. A., Armstrong, D. K., Brundage, M., Gourley, C., Romero, I., Gonzalez-Martin, A., Feeney, M., Bessette, P., Hall, M., Weberpals, J. I., Hall, G., Lau, S. K., Gauthier, P., Fung-Kee-Fung, M., Eisenhauer, E. A., Winch, C., ... Mackay, H. J. (2018). OV21/PETROC: A randomized gynecologic cancer intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer. Obstetrical and Gynecological Survey, 73(4), 209-210. https://doi.org/10.1097/OGX.0000000000000541